UK markets open in 4 hours 36 minutes
NIKKEI 225
36,876.37 -1,203.33 (-3.16%) HANG SENG
16,225.46 -160.41 (-0.98%) CRUDE OIL
85.80 +3.07 (+3.71%) GOLD FUTURES
2,426.80 +28.80 (+1.20%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
48,353.95 -1,258.18 (-2.54%)
Cumberland Pharmaceuticals Inc. (CPIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 22.26M |
| Enterprise value | 22.36M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.57 |
| Price/book (mrq) | 0.75 |
| Enterprise value/revenue | 0.57 |
| Enterprise value/EBITDA | 9.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.17 |
| 52-week change 3 | -14.06% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 2.3600 |
| 52-week low 3 | 1.4300 |
| 50-day moving average 3 | 1.8944 |
| 200-day moving average 3 | 1.8232 |
Share statistics
| Avg vol (3-month) 3 | 10.26k |
| Avg vol (10-day) 3 | 7.03k |
| Shares outstanding 5 | 14.18M |
| Implied shares outstanding 6 | 14.18M |
| Float 8 | 8.02M |
| % held by insiders 1 | 44.06% |
| % held by institutions 1 | 15.57% |
| Shares short (28 Mar 2024) 4 | 16.97k |
| Short ratio (28 Mar 2024) 4 | 1.51 |
| Short % of float (28 Mar 2024) 4 | 0.21% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.12% |
| Shares short (prior month 29 Feb 2024) 4 | 23.91k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -15.88% |
| Operating margin (ttm) | -30.31% |
Management effectiveness
| Return on assets (ttm) | -4.44% |
| Return on equity (ttm) | -19.41% |
Income statement
| Revenue (ttm) | 39.55M |
| Revenue per share (ttm) | 2.77 |
| Quarterly revenue growth (yoy) | 2.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.27M |
| Net income avi to common (ttm) | -6.28M |
| Diluted EPS (ttm) | -0.4400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 18.32M |
| Total cash per share (mrq) | 1.29 |
| Total debt (mrq) | 18.43M |
| Total debt/equity (mrq) | 62.98% |
| Current ratio (mrq) | 1.28 |
| Book value per share (mrq) | 2.10 |
Cash flow statement
| Operating cash flow (ttm) | 6.09M |
| Levered free cash flow (ttm) | 9.33M |
© 2024 Yahoo. All rights reserved.